FGL1 and neoplasm: Furthermore, research suggests that elevated levels of FGL1 in circulating tumor cells may be associated with resistance to programmed cell death protein-1 and its ligand PD-L1 (PD-1/PD-L1) immune checkpoint inhibitors [116].